Practicing Personalized Evidence-Based Medicine in CLL through Risk Stratification and Patient Education

Practicing Personalized Evidence-Based Medicine in CLL through Risk Stratification and Patient Education
Practicing Personalized Evidence-Based Medicine in CLL through Risk Stratification and Patient Education
CME, CPE, CNE
Beth Faiman, PhD, CNP; Heidi D. Finnes, PharmD, BCOP; Jeffrey Jones, MD
Release Date: January 17, 2017
Expiration Date: January 17, 2018

In this activity, our multidisciplinary team of experts will present key risk-stratification strategies and associated treatment pathways for patients with CLL. Aspects of care that are critical to improved patient outcomes from an interdisciplinary point of view will be discussed, including concomitant medications and important aspects of patient monitoring. In addition, participants will gain an understanding of the role of shared decision-making and communication strategies to engage their patients in ongoing discussions related to their diagnosis and treatment.

As a bonus resource, we invite you to participate in the added benefits of this activity:

  • E-mentorship Opportunity ‒ Still have questions following the activity? This is your opportunity to connect with one or more of our clinical experts. By clicking on “submit your questions,” you will have the opportunity to ask your questions and receive a response from our faculty
  • Patient Education Handouts Easy to understand patient information related to the diagnosis and management of CLL. Valuable resources to share and discuss with your patients
  • Educational Slide Set ‒ Access the slides used in our video presentation for sharing with your colleagues, treatment team, or patients
  • Peer Questions, Expert Answers ‒ View a collection of previously asked questions and faculty responses

Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Genentech

Begin, Earn CreditView Only, No Credit